Abstract
Intact parathyroid hormone (iPTH) measurements are used to guide therapy in renal patients, but variability in results can occur depending on the assay used. This study has investigated iPTH assay variation in North West England and paired data with regional audit data to determine clinical relevance of assay variability.
Original language | English |
---|---|
Pages (from-to) | 228-236 |
Journal | Annals of Clinical Biochemistry |
Volume | 51 |
Issue number | 2 |
Early online date | 2 Sept 2013 |
DOIs | |
Publication status | Published - Mar 2014 |
Keywords
- Renal disease
- clinical studies
- parathyroid hormone
- chronic kidney disease
- PTH assay
- haemodialysis